HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Hsin Wang Selected Research

lumbrokinase

12/2022Lumbrokinase regulates endoplasmic reticulum stress to improve neurological deficits in ischemic stroke.
1/2018Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury.
10/2016Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Hsin Wang Research Topics

Disease

4Infections
02/2023 - 05/2015
3Diarrhea
02/2023 - 12/2017
3Stroke (Strokes)
12/2022 - 10/2016
3Infarction (Infarctions)
12/2022 - 10/2016
3Ischemic Stroke
12/2022 - 12/2021
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2022 - 12/2021
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 10/2016
2Myocardial Infarction
01/2020 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 10/2016
2Neoplasms (Cancer)
01/2018 - 04/2013
2Reperfusion Injury
01/2018 - 10/2016
2Thrombocytopenia (Thrombopenia)
12/2017 - 05/2014
2Sepsis (Septicemia)
12/2015 - 05/2015
1Dysbiosis
02/2023
1Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2022
1Hemorrhage
12/2022
1Stable Angina
12/2022
1Neuroinflammatory Diseases
07/2022
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Disease Resistance
09/2019
1Cardiomegaly (Heart Hypertrophy)
01/2019
1Inflammation (Inflammations)
01/2018
1Hyperglycemia
12/2017
1Leukopenia
12/2017
1Fever (Fevers)
12/2017
1Hyponatremia
12/2017
1Cysts
04/2013
1Noma (Nomas)
04/2013
1Channelopathies
01/2013
1Timothy syndrome
01/2013
1Andersen Syndrome
01/2013

Drug/Important Bio-Agent (IBA)

3Anti-Bacterial Agents (Antibiotics)IBA
02/2023 - 12/2017
3lumbrokinaseIBA
12/2022 - 10/2016
3ImipenemFDA Link
06/2018 - 05/2015
2Factor XI (Plasma Thromboplastin Antecedent)IBA
12/2021 - 01/2019
2C-Reactive ProteinIBA
12/2017 - 05/2014
1PrebioticsIBA
02/2023
1Fibrinogen (Factor I)FDA Link
12/2022
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2022
1Therapeutic UsesIBA
07/2022
1MentholFDA Link
07/2022
1Lidocaine (Xylocaine)FDA LinkGeneric
07/2022
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
12/2021
1paeonolIBA
01/2020
1Troponin IIBA
01/2020
1calloseIBA
09/2019
1Transforming Growth Factor beta (TGF-beta)IBA
01/2019
1Colistin (Coly-Mycin)FDA Link
06/2018
1Heme (Haem)IBA
01/2018
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2018
1Sirtuin 1IBA
01/2018
1EnzymesIBA
01/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2017
1Inflammation MediatorsIBA
10/2016
1Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2016
1Ethanol (Ethyl Alcohol)IBA
04/2013
1Proteins (Proteins, Gene)FDA Link
01/2013
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2013
1Ion Channels (Ion Channel)IBA
01/2013

Therapy/Procedure

4Therapeutics
07/2022 - 05/2015
1High-Frequency Ventilation
06/2018
1Oral Administration
01/2018
1Punctures
04/2013
1Drug Therapy (Chemotherapy)
01/2013
1Catheter Ablation
01/2013